Schedule 13D ownership disclosure

INNOVATE BIOPHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 45782F105

Event date: 2020-05-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
27.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-20-000465
Form type
SC 13D
Filer
9 METERS BIOPHARMA, INC.
CIK
CIK 1551986
Filed
May 14, 2020
Reporting period
May 04, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub